Drug price history · CMS NADAC read 11 November 2026
Generic
$0.049 per mL at the 2013 year-end survey (6 NDCs) and $0.540 at the 2026 survey (11 NDCs): +1011%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.049 | $0.032 to $0.071 | 6 |
| 2014 (2014-12-31) | $0.063 | $0.039 to $0.071 | 6 |
| 2015 (2015-12-30) | $0.070 | $0.045 to $0.075 | 6 |
| 2016 (2016-12-28) | $0.067 | $0.045 to $0.079 | 6 |
| 2017 (2017-12-27) | $0.058 | $0.039 to $0.073 | 6 |
| 2018 (2018-12-26) | $0.072 | $0.042 to $0.077 | 4 |
| 2019 (2019-12-25) | $0.105 | $0.045 to $0.119 | 4 |
| 2020 (2020-12-30) | $0.095 | $0.043 to $0.106 | 4 |
| 2021 (2021-12-29) | $0.140 | $0.107 to $0.188 | 4 |
| 2022 (2022-12-28) | $0.126 | $0.113 to $0.204 | 6 |
| 2023 (2023-12-27) | $0.128 | 3 | |
| 2024 (2024-12-25) | $0.584 | $0.109 to $0.627 | 7 |
| 2025 (2025-12-31) | $0.553 | $0.119 to $0.622 | 9 |
| 2026 (2026-11-11) | $0.540 | $0.103 to $0.607 | 11 |
Generic
$0.575 per mL at the 2013 year-end survey (2 NDCs) and $0.549 at the 2026 survey (2 NDCs): −4%, a thin comparison.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.575 | 2 | |
| 2014 (2014-12-31) | $0.571 | 2 | |
| 2015 (2015-12-30) | $0.584 | 2 | |
| 2016 (2016-12-28) | $0.654 | 3 | |
| 2017 (2017-12-27) | $0.531 | 2 | |
| 2018 (2018-12-26) | $0.575 | 2 | |
| 2019 (2019-12-25) | $0.555 | 2 | |
| 2020 (2020-12-30) | $0.608 | 2 | |
| 2021 (2021-12-29) | $0.585 | 3 | |
| 2022 (2022-12-28) | $0.565 | 3 | |
| 2023 (2023-12-27) | $0.522 | 3 | |
| 2024 (2024-12-25) | $0.544 | 3 | |
| 2025 (2025-12-31) | $0.558 | 2 | |
| 2026 (2026-11-11) | $0.549 | 2 |
Generic
$0.040 per mL at the 2013 year-end survey (2 NDCs) and $0.573 at the 2026 survey (2 NDCs): +1326%, a thin comparison.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.040 | $0.032 to $0.049 | 2 |
| 2014 (2014-12-31) | $0.051 | $0.039 to $0.063 | 2 |
| 2015 (2015-12-30) | $0.057 | $0.045 to $0.070 | 2 |
| 2016 (2016-12-28) | $0.056 | $0.045 to $0.067 | 2 |
| 2017 (2017-12-27) | $0.049 | $0.039 to $0.058 | 2 |
| 2018 (2018-12-26) | $0.055 | $0.042 to $0.067 | 2 |
| 2025 (2025-12-31) | $0.587 | $0.553 to $0.622 | 2 |
| 2026 (2026-11-11) | $0.573 | $0.540 to $0.607 | 2 |
Generic
$1.96 per mL at the 2024 year-end survey (2 NDCs) and $2.43 at the 2026 survey (2 NDCs): +24%, a thin comparison.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2024 (2024-12-25) | $1.96 | 2 | |
| 2025 (2025-12-31) | $2.43 | 2 | |
| 2026 (2026-11-11) | $2.43 | 2 |
Generic
$8.54 per unit at the 2024 year-end survey (3 NDCs) and $8.30 at the 2026 survey (3 NDCs): −3%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2024 (2024-12-25) | $8.54 | 3 | |
| 2025 (2025-12-31) | $10.39 | 3 | |
| 2026 (2026-11-11) | $8.30 | 3 |
Generic
Priced once, at the 2024 year-end survey: $2.45 per mL across 2 NDCs.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2024 (2024-12-25) | $2.45 | 2 |
Generic
Priced once, at the 2016 year-end survey: $10.41 per unit across 2 NDCs.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2016 (2016-12-28) | $10.41 | 2 |
Generic
Priced once, at the 2015 year-end survey: $18.60 per unit across 2 NDCs.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2015 (2015-12-30) | $18.60 | 2 |
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
Prednisolone 5 MG Tablet: the first generic approval in its Orange Book group is dated 2013. Its year-end acquisition cost in 2026 is 97% of its first observed year-end price (2024). The median matched product, 13 years after its first generic approval, is at 19% (the middle half runs from 14% to 39%), so this product is above that middle half.
This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).